Immatics NV Stock Update
Immatics NV (ticker 4A3.F) closed the trading session on Monday, 26 April 2026, 0.59 % lower than its previous close. At 09:40 AM Central European Time the share price stood at EUR 6.75.
Trading Statistics
| Item | Value |
|---|---|
| Current share price | EUR 6.75 |
| Total shares outstanding | 152.2 million |
| Market capitalization | EUR 1 billion |
| 24‑hour volume | EUR 5 k |
| 24‑hour price change | –0.59 % |
| Month‑to‑date change | –9.7 % |
| 200‑day simple moving average | EUR 8.28 |
| 52‑week high | EUR 10.15 (08 Jul 2026) |
| 52‑week low | EUR 5.92 (19 Oct 2026) |
Comparative Performance of Related Stocks (24‑hour)
| Company | Ticker | 24‑hour change | Current price | Market cap | P/E ratio (if available) |
|---|---|---|---|---|---|
| H&k | MLHK.PA | –3.12 % | EUR 31.00 | EUR 1.1 billion | 17.39 |
| Chapters | CHG.DE | –6.59 % | EUR 45.05 | EUR 1.1 billion | – |
| Gerresheimer | GXI.DE | –2.06 % | EUR 31.58 | EUR 1.1 billion | – |
| Duerr | DUE.DE | +0.63 % | EUR 16.12 | EUR 1.1 billion | – |
| Teamviewer | TMV.DE | –0.47 % | EUR 7.46 | EUR 1.2 billion | 8.18 |
Company Overview
Immatics NV is a biotechnology firm headquartered in Tübingen, Germany. The company focuses on the discovery of cancer immunotherapies and serves a global customer base. It is listed on the Frankfurt Stock Exchange and provides further details on its website at www.immatics.com .